Novo Nordisk A/S (NONOF) has a market capitalization of $172.47B and trades at $38.82. The 52-week range is 34-82.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 1.7, Earnings Per Share (EPS) of $23.00, annual revenue of $308.36B.
The stock has a beta of 0.27, a last dividend of $1.4776, operates in the Healthcare sector.
